Vedolizumab-induced cholestatic liver injury

Gastroenterol Hepatol. 2022 Jan;45(1):64-65. doi: 10.1016/j.gastrohep.2020.11.009. Epub 2020 Nov 25.
[Article in English, Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged, 80 and over
  • Anti-Inflammatory Agents / administration & dosage
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Chemical and Drug Induced Liver Injury / diagnosis
  • Chemical and Drug Induced Liver Injury / drug therapy
  • Chemical and Drug Induced Liver Injury / etiology*
  • Cholestasis, Intrahepatic / chemically induced*
  • Cholestasis, Intrahepatic / diagnosis
  • Cholestasis, Intrahepatic / drug therapy
  • Colitis, Ulcerative / drug therapy*
  • Gastrointestinal Agents / administration & dosage
  • Gastrointestinal Agents / adverse effects*
  • Humans
  • Maintenance Chemotherapy
  • Male
  • Prednisone / administration & dosage

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal, Humanized
  • Gastrointestinal Agents
  • vedolizumab
  • Prednisone